SOM BiotechListed
sombiotech.combiotech_life_sciences
SOM Biotech is a late clinical-stage biopharmaceutical company focused on discovering and developing new impactful treatments for rare diseases of the CNS using an AI-driven platf…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
SOM Biotech is a late clinical-stage biopharmaceutical company focused on discovering and developing new impactful treatments for rare diseases of the CNS using an AI-driven platf…
Details are not available yet. The company remains listed.
Neurofenix is a tech-enabled virtual care provider that helps neurological patients achieve their rehabilitation goals at home through personalized, engaging, and evidence-based t…
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Leuko is developing PointCheck™, the first device for non-invasive white blood cell monitoring. This portable device allows for fast and simple assessment of white blood cell leve…
SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - desig…